Autologous Adipose-Derived Mesenchymal Stem Cells for Chronic Traumatic Brain Injury
Phase 2
51
about 2.7 years
18–55
2 sites in TX
What this study is about
Researchers are testing a treatment with autologous HB-adMSCs to see if it can improve brain structure, cognitive function, and reduce inflammation after traumatic brain injury. The trial will last about 989 days.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Receive Autologous HB-adMSCs
- 2.Take Normal Saline
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Primary: Alanine aminotransferase, Aspartate aminotransferase, Creatinine, Glucose
Secondary: Brief Symptom Inventory 18, Interleukin 6, PET/DT-MRI (positron emission tomography/Diffusion tensor-Magnetic resonance imaging), TBI (Traumatic Brain Injury) Quality of Life Questionnaires, Whole brain MRI (Magnetic resonance imaging)